Hematology News

As a disease that traditionally has been thought to only affect men, hemophilia has acquired the false reputation of being a “male-only” disease.

ASH will honor Donna S. Neuberg, ScD, with the 2021 Exemplary Service Award at this year’s ASH Annual Meeting, scheduled for Dec. 11-14.

The national blood inventory is at its lowest level for this time of the year since 2015, according to the Red Cross.

To advance health equity, it is time to normalize the collection of sexual orientation and gender identity (SOGI) data in clinical practice and in health services research.

Standard cancer care may fail to adequately address the needs of LGBTQ+ individuals, who face substantial disparities in access to screening, treatment and outcomes.

The FDA received a completed rolling biologics license application for betibeglogene autotemcel, a gene therapy in development to treat patients with transfusion-dependent beta-thalassemia.

Adding mycophenolate mofetil to a glucocorticoid in first-line treatment for immune thrombocytopenia improves response and decreases the risk for refractory or relapsed disease, according to data.

Patients who continued to use anticoagulant therapy beyond the initial 3 to 6 months of treatment for a first unprovoked venous thromboembolism were at “considerable” risk for major bleeding, researchers wrote.

Ferritin testing needs to be a routine part of maternal care and pregnancy health screenings, according to the authors of a study published in Blood Advances.

The FDA granted priority review to voxelotor for the treatment of children aged 4 to 11 years with sickle cell disease.